Second Sight Medical Products

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch EYES and buy or sell other stocks, options, and ETFs commission-free!

About EYES

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. Its product, the Argus II Retinal Prosthesis System, treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. 

CEO
Jonathan Will McGuire
CEOJonathan Will McGuire
Employees
123
Employees123
Headquarters
Sylmar, California
HeadquartersSylmar, California
Founded
1998
Founded1998
Employees
123
Employees123

EYES Key Statistics

Market cap
515.84M
Market cap515.84M
Price-Earnings ratio
0.00
Price-Earnings ratio0.00
Dividend yield
0.00
Dividend yield0.00
Average volume
297.74K
Average volume297.74K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.20
52 Week high$1.20
52 Week low
$0.64
52 Week low$0.64

EYES Earnings

-$0.49
-$0.33
-$0.16
$0.00
Q2 FY18
Q3 FY18
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Estimated
per share
Estimated per share
Actual
Expected May 16, After Hours
ActualExpected May 16, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.